参考文献
1. Hashemi SY, et al. Trends in burden of chronic obstructive pulmonary disease in Iran, 1995–2015: fndings from the global burden of disease study. Archiv Public Health. 2020;78(1):45.
2. Abbaszadeh, H., Ghorbani, F., Abbaspour-Aghdam, S. et al. Chronic obstructive pulmonary disease and asthma: mesenchymal stem cells and their extracellular vesicles as potential therapeutic tools. Stem Cell Res Ther 13, 262 (2022). https://doi.org/10.1186/s13287-022-02938-5
3. Gu W, et al. Mesenchymal stem cells alleviate airway infammation and emphysema in COPD through down-regulation of cyclooxygenase-2 via p38 and ERK MAPK pathways. Sci Rep. 2015;5(1):8733.
4. Kennelly H, Mahon BP, English K. Human mesenchymal stromal cells exert HGF dependent cytoprotective efects in a human relevant preclinical model of COPD. Sci Rep. 2016;6(1):38207.
5. Chen M, et al. Efects of bone marrow-derived mesenchymal stem cell transplantation on chronic obstructive pulmonary disease/ obstructive sleep apnea overlap syndrome in rats. Mol Med Rep. 2019;20(5):4665–73.
6. Stolk J, et al. A phase I study for intravenous autologous mesenchymal stromal cell administration to patients with severe emphysema. QJM. 2016;109(5):331–6.
7. Weiss DJ, et al. A placebo-controlled, randomized trial of mesenchymal stem cells in COPD. Chest. 2013;143(6):1590–8.
8. Kim Y-S, et al. Gene profles in a smoke-induced COPD mouse lung model following treatment with mesenchymal stem cells. Mol Cells. 2016;39:728.
9. Hoang DM, et al. Allogeneic human umbilical cord-derived mesen‑chymal stem/stromal cells for chronic obstructive pulmonary disease (COPD): study protocol for a matched case-control, phase I/II trial. BMJ Open. 2021;11(5): e045788.
10. Squassoni SD, et al. Autologous infusion of bone marrow and mesen‑hymal stromal cells in patients with chronic obstructive pulmonary disease: phase I randomized clinical trial. Int J Chron Obstruct Pulm Dis. 2021;16:3561–74
11. Zhou J, et al. HMSC-derived exosome inhibited Th2 cell diferentia‑tion via regulating miR-146a-5p/SERPINB2 pathway. J Immunol Res. 2021;2021:6696525.
12. Du YM, et al. Mesenchymal stem cell exosomes promote immu‑nosuppression of regulatory T cells in asthma. Exp Cell Res. 2018;363(1):114–20
13. Harrell CR, et al. Molecular and cellular mechanisms responsible for benefcial efects of mesenchymal stem cell-derived product “Exo-dMAPPS” in attenuation of chronic airway infammation. Anal Cell Pathol (Amst). 2020;2020:3153891.
14. Chen Y, et al. Mesenchymal stem cell-based HSP70 promoter-driven VEGFA induction by resveratrol alleviates elastase-induced emphysema in a mouse model. Cell Stress Chaperones. 2015;20:979–89.
15. Maremanda KP, Sundar IK, Rahman I. Protective role of mesenchymal stem cells and mesenchymal stem cell-derived exosomes in cigarette smoke-induced mitochondrial dysfunction in mice. Toxicol Appl Phar‑macol. 2019;385: 114788.
16. Feng CY, et al. Adipose-derived mesenchymal stem cell-derived exoso‑mal miR-301a-3p regulates airway smooth muscle cells during asthma by targeting STAT3. J Asthma Allergy. 2022;15:99–110.
17. Dong L, et al. Hypoxic hUCMSC-derived extracellular vesicles attenuate allergic airway infammation and airway remodeling in chronic asthma mice. Stem Cell Res Ther. 2021;12(1):4.
